Article Type
Changed
Thu, 03/28/2019 - 15:54
Display Headline
Cost and response criteria are the new challenges

Although the concept of using immunotherapy to target an immune response against tumors is not new, this treatment modality is only now  beginning to realize its full potential. Here, we take a look at the role of immunotherapy in cancer and some of the most exciting areas of clinical development.

*Click on the link to the left for a PDF of the full article.

Article PDF
Author and Disclosure Information

 

 

Publications
Topics
Legacy Keywords
immunotherapy, monoclonal antibodies, mAbs, adoptive cell therapy, sipuleucel-T
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

Although the concept of using immunotherapy to target an immune response against tumors is not new, this treatment modality is only now  beginning to realize its full potential. Here, we take a look at the role of immunotherapy in cancer and some of the most exciting areas of clinical development.

*Click on the link to the left for a PDF of the full article.

Although the concept of using immunotherapy to target an immune response against tumors is not new, this treatment modality is only now  beginning to realize its full potential. Here, we take a look at the role of immunotherapy in cancer and some of the most exciting areas of clinical development.

*Click on the link to the left for a PDF of the full article.

Publications
Publications
Topics
Article Type
Display Headline
Cost and response criteria are the new challenges
Display Headline
Cost and response criteria are the new challenges
Legacy Keywords
immunotherapy, monoclonal antibodies, mAbs, adoptive cell therapy, sipuleucel-T
Legacy Keywords
immunotherapy, monoclonal antibodies, mAbs, adoptive cell therapy, sipuleucel-T
Sections
Disallow All Ads
Alternative CME
Article PDF Media